P

Inventor

ZHANG JACK YONGFENG

US20 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG JACK YONGFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMPHASTAR PHARMACEUTICALS INC

16 patents
US6793076B1Sep 21, 2004

Glass bottle protective enclosure

AMPHASTAR PHARMACEUTICALS INC69 citations93
US6399087B1Jun 4, 2002

Propofol formulation with enhanced microbial inhibition

AMPHASTAR PHARMACEUTICALS INC76 citations93
US6827479B1Dec 7, 2004

Uniform small particle homogenizer and homogenizing process

AMPHASTAR PHARMACEUTICALS INC34 citations91
US6457612B1Oct 1, 2002

Sealable and manipulable pre-filled disposable pipette

AMPHASTAR PHARMACEUTICALS INC38 citations91
US8367734B1Feb 5, 2013

Stable epinephrine suspension formulation with high inhalation delivery efficiency

AMPHASTAR PHARMACEUTICALS INC50 citations90
US7219816B1May 22, 2007

Easily sealed and opened pre-filled, disposable pipette

AMPHASTAR PHARMACEUTICALS INC19 citations82
US7468394B1Dec 23, 2008

Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

AMPHASTAR PHARMACEUTICALS INC3 citations62
US11446360B2Sep 20, 2022

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

AMPHASTAR PHARMACEUTICALS INC0 citations58
US12383516B1Aug 12, 2025

Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

AMPHASTAR PHARMACEUTICALS INC0 citations57
US12496272B1Dec 16, 2025

Stable epinephrine suspension formulation for inhalation with HFO propellant

AMPHASTAR PHARMACEUTICALS INC0 citations52
US10406210B2Sep 10, 2019

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

AMPHASTAR PHARMACEUTICALS INC0 citations48
US10322168B2Jun 18, 2019

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

AMPHASTAR PHARMACEUTICALS INC0 citations48
US11524987B2Dec 13, 2022

Highly purified recombinant human insulin (RHI) API and methods of producing the same

AMPHASTAR PHARMACEUTICALS INC0 citations46
US12564562B2Mar 3, 2026

Injectable epinephrine formulations demonstrating stability over time

AMPHASTAR PHARMACEUTICALS INC0 citations42
US11726049B2Aug 15, 2023

Small angle x-ray scattering methods for characterizing the iron core of iron carbohydrate colloid drug products

AMPHASTAR PHARMACEUTICALS INC0 citations38
US10258573B2Apr 16, 2019

Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions

AMPHASTAR PHARMACEUTICALS INC0 citations37

(unassigned)

3 patents

ZHANG JACK YONGFENG

1 patent